Results 191 to 200 of about 13,040 (222)

Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Expert Opinion on Biological Therapy, 2020
Jong Wook Lee, Austin G Kulasekararaj
exaly  

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.

Journal of Experimental Medicine, 1987
L S Zalman, M M Frank, H J Muller-Eberhard   +2 more
exaly  

HEMOGLOBINURIA

Physiological Reviews, 1942
openaire   +1 more source

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.

Journal of Experimental Medicine, 1983
M K Pangburn, Robert D Schreiber, Pangburn M K   +2 more
exaly  

Paroxysmal Nocturnal Hemoglobinuria: An Historical Overview

Hematology American Society of Hematology Education Program, 2008
Charles J Parker, Parker Charles J
exaly  

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Therapeutic Advances in Hematology, 2019
Robert M Stern, Nathan T Connell
exaly  

Leukemia Arising out of Paroxysmal Nocturnal Hemoglobinuria

Leukemia and Lymphoma, 1999
John W Harris, James R Eshleman, M Edward Medof   +2 more
exaly  

Pathology of Naturally Occurring Bacillary Hemoglobinuria in Cattle

Veterinary Pathology, 2017
Fernando Dutra, Antonio Romero, J C Freedman   +2 more
exaly  

New insights into paroxysmal nocturnal hemoglobinuria

Hematology, 2007
William J Savage, Robert A Brodsky
exaly  

Hemoglobinuria

2020
openaire   +1 more source